Revolutionizing Imaging Diagnostics with Cortechs.ai CEO, Kyle Frye

Cortechs.ai CEO Kyle Frye Featured on SCALE Community Healthcare Technology & Innovation Podcast

We’re excited to share that Kyle Frye, CEO of Cortechs.ai, recently sat down with the SCALE Community Healthcare Technology & Innovation Podcast for an insightful conversation about the future of medical technology. As a market leader and innovator in AI-powered solutions for neurology, radiology, and oncology, Cortechs.ai is transforming healthcare through advanced imaging technologies.

In this episode, Kyle dives into how Cortechs.ai leverages clinical data and machine learning to empower physicians with more accurate and timely diagnostic insights. Listeners will hear about the company’s pioneering advancements, such as their state-of-the-art imaging solutions that improve patient outcomes and streamline clinical workflows.

Key topics discussed include:

  • The impact of AI-powered quantitative MRI in transforming radiology
  • Innovative solutions for neuroimaging and prostate cancer diagnosis
  • How data-driven insights are revolutionizing the decision-making process for physicians
  • The company’s vision for continued innovation in healthcare technology

Don’t miss this engaging conversation with Kyle as he shares how Cortechs.ai is shaping the future of medical imaging and empowering healthcare professionals worldwide.

You can listen to the podcast on:

Tune in to discover how Cortechs.ai is advancing clinical care through cutting-edge technology!

More Resources

03/06/2025

Case Study: Leveraging NeuroQuant® for Accurate Diagnosis of Traumatic Brain Injury

This case highlights the power of advanced neuroimaging tools in delivering precise, evidence-based diagnostics to enhance patient care and clinical decisions.

02/26/2025

Traumatic Brain Injury in Athletes: The Role of the NeuroQuant and Automated Volumetric Tracking

NeuroQuant enables objective brain volume tracking for early TBI detection, recovery monitoring, and safer return-to-play decisions.

02/25/2025

OnQ™ Prostate Solution Enhances Collaboration and Improves MRI for Cancer Detection with RSI Technology

OnQ Prostate enhances MRI tissue characterization, improving sensitivity and specificity in cancer detection, & bridges gaps between radiologists and urologists

02/15/2025

NeuroQuant® Dementia: Advancing Alzheimer’s Disease Care in the Era of DMTs

AI-driven brain volumetric analysis is revolutionizing Alzheimer’s care, providing precise diagnostic support, monitoring, and early detection.

02/09/2025

NeuroQuant® MS:  Advancing Precision in Multiple Sclerosis

Dr. Suzie Bash discusses NeuroQuant MS, noting its ability to segment plaques, analyze volume, and track lesion burden for assessing disease progression

02/09/2025

Epilepsy Care with NeuroQuant Seizure: The Power of Quantifying Hippocampal Asymmetry

Accurate imaging of the hippocampus is crucial for effective diagnosis and treatment planning in TLE, with structural abnormalities linked to seizure onset
Scroll to Top